Back

Cholesterol-Years and the risk of the first MI

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes (2) Acute Myocardial Ischaemia ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

5 More presentations in this session

Presentation thumbnail
Impact of new-onset versus preexisting atrial fibrillation on short- and long-term mortality in patients with STEMI treated with primary PCI
Doctor M. Klaric (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Predictive value of lung ultrasound combined with ACEF score in patients with acute myocardial infarction
Doctor Y. Zhang (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Reticulated platelets predict cardiovascular death and adverse events in coronary artery disease
Doctor D. Bongiovanni (Augsburg, DE)
Abstract Slides Video
Presentation thumbnail
Myocardial salvage and infarct characteristics in patients with ST-elevation myocardial infarction classified by ORBI risk score
Mr J. Kunkel (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting
Associate Professor J. Kim (Yangsan, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) as a predictive marker of coronary artery calcification (CAC). The results from the STAR-Lp(a) cohort study.
thumbnail
Congress Presentation
Missed opportunity in primary prevention: an analysis of acute myocardial infarction patients with no history of atherosclerotic cardiovascular disease
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources